Nonhomologous end joining (NHEJ) is the primary pathway of DNA double-strand-break repair in vertebrate cells, yet how NHEJ factors assemble a synaptic complex that bridges DNA ends remains unclear. To address the role of XRCC4-like factor (XLF) in synaptic-complex assembly, we used single-molecule fluorescence imaging in Xenopus laevis egg extract, a system that efficiently joins DNA ends. We found that a single XLF dimer binds DNA substrates just before the formation of a ligationcompetent synaptic complex between DNA ends. The interaction of both globular head domains of the XLF dimer with XRCC4 is required for efficient formation of this synaptic complex. Our results indicate that, in contrast to a model in which filaments of XLF and XRCC4 bridge DNA ends, binding of a single XLF dimer facilitates the assembly of a stoichiometrically well-defined synaptic complex. NATure STruCTurAL & MoLeCuLAr BioLoGy | VOL 25 | SEPTEMBER 2018 | 877-884 | www.nature.com/nsmb 877
C anonical NHEJ is the major pathway of DNA double-strand break (DSB) repair in vertebrate cells. Successful rejoining of broken DNA ends requires that they be held together in a manner that permits their processing and ligation. DNA ends are first bound by the Ku heterodimer, composed of Ku70 and Ku80, which fits over the DNA end like a ring 1 . Ku recruits the DNAdependent protein kinase catalytic subunit (DNA-PKcs), whose kinase activity is required for efficient end joining [2] [3] [4] . Ends are ultimately ligated by DNA ligase 4 (LIG4), which resides in a complex with XRCC4 (refs 5, 6 ). A homolog of XRCC4, named XLF or Cernunnos, was identified as an XRCC4-interacting protein whose disruption in humans results in immunodeficiency, developmental defects, and cellular radiosensitivity 7, 8 . Despite the identification of these core components of the NHEJ machinery, the nature of the synaptic complex that aligns broken DNA ends, in particular the roles of XLF and XRCC4-LIG4, remains poorly defined.
Structural characterization of XLF and XRCC4 has revealed that both proteins form symmetric homodimers that interact through their globular head domains [9] [10] [11] [12] [13] [14] , and mutations in XLF or XRCC4 that disrupt this interaction impair NHEJ in cell culture-based assays [15] [16] [17] . Two possible roles of the XLF-XRCC4 interaction in NHEJ have been proposed. First, XLF may directly promote catalysis by XRCC4-LIG4. XLF stimulates XRCC4-LIG4 activity in vitro, especially on noncohesive and mismatched ends [17] [18] [19] [20] [21] . XLF likewise increases the rate of LIG4 autoadenylation, the initial step in the LIG4 catalytic cycle 22 . The second proposal is that alternating filaments of XLF and XRCC4 bridge broken DNA ends. Filaments of purified XLF and XRCC4 are seen in crystal structures and electron micrographs [12] [13] [14] [23] [24] [25] , and a mixture of XLF and XRCC4 bridges DNA molecules in bulk and single-molecule assays 16, 17, 25, 26 . Additionally, super-resolution imaging of fixed cells stained with anti-XLF or anti-XRCC4 antibodies has revealed elongated nuclear foci proposed to be XLF-XRCC4 filaments 27 . Although these results are suggestive, XLF-XRCC4 filaments have not been demonstrated to be necessary for physiological end joining.
To study the role of the XLF-XRCC4 interaction in NHEJ, we used Xenopus laevis egg extract, which performs efficient NHEJ dependent on the core pathway components Ku, DNA-PKcs, XLF, XRCC4, and LIG4 (refs [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] ). We previously combined this cell-free system with a single-molecule Förster resonance energy transfer (smFRET) assay that allowed us to visualize synapsis of single pairs of DNA ends during NHEJ 37, 38 . These experiments revealed a stepwise transition from an initial 'long-range' synaptic complex (LR complex), in which DNA ends are physically tethered but not held closely together, to a 'short-range' synaptic complex (SR complex), in which DNA ends are closely aligned for ligation. The SR complex either ligates DNA ends or dissociates, requiring another round of SR-complex formation before eventual ligation. Formation of the LR complex requires Ku and DNA-PKcs, in agreement with the previously reported dimerization and DNA end-bridging activities of the DNA-PK holoenzyme [39] [40] [41] [42] . Transition from the LR complex to the SR complex requires DNA-PK catalytic activity, XLF, and XRCC4-LIG4, but not LIG4 catalytic activity. A noncatalytic role of LIG4 in the stable bridging of DNA ends is consistent with previous results from pulldown experiments in mammalian cell-free extracts 43 . A subsequent study in a reconstituted mixture of human NHEJ proteins has indicated a transition from a transient synaptic complex dependent on Ku and DNA-PKcs to a more stable complex dependent on XLF and XRCC4-LIG4 (ref. 44 ). These observations closely parallel our results in Xenopus egg extract, thus suggesting that the mechanisms of synaptic-complex assembly are conserved between frogs and humans.
Here, we investigated the role of the XLF-XRCC4 interaction in synaptic-complex formation. Using X. laevis egg extract, we show that the XLF-XRCC4 interaction is required for formation of the SR complex. In three-color single-molecule imaging experiments, we visualized binding of fluorescently labeled XLF protein to individual DNA substrates undergoing synapsis. Strikingly, formation of the SR complex involves association of only a single XLF dimer with DNA ends. Experiments with a synthetic XLF tandem dimer imply that XLF nonetheless interacts with XRCC4 through both globular head domains of the XLF dimer. These results support a model in which XLF binds with defined stoichiometry to the synaptic complex, thereby facilitating a structural rearrangement that closely aligns DNA ends. The XRCC4 K104E mutation weakened but did not eliminate interaction with XLF ( Fig. 1a ), thus reflecting a higher dissociation rate ( Supplementary Fig. 1e ,f). The denaturation temperatures of all mutants, measured by differential scanning fluorimetry, were within 1.45 °C of the wild-type (WT) protein, thus suggesting that the defect is not due to large-scale misfolding ( Supplementary  Fig. 1g ). Mutations that disrupted the XLF-XRCC4 interaction also disrupted formation of large XLF-XRCC4 complexes in DLS experiments and abolished DNA bridging in pulldown experiments ( Supplementary Fig. 1c,d) .
We next tested whether interaction-deficient XLF and XRCC4 mutants might support cell-free NHEJ. Egg extract was immunodepleted of XLF or XRCC4, thus abolishing end joining of linear DNA substrates (Fig. 1c,d and ref. 38 ). This effect was fully rescued by addition of recombinant XLF to XLF-depleted extract (Fig. 1c ) or by addition of recombinant XRCC4-LIG4 to XRCC4-depleted extract ( Fig. 1d ; of note, depletion of XRCC4 codepletes LIG4 (ref. 38 )). In contrast, XLF L117D and XLF L68D did not rescue end joining in XLFdepleted egg extract (Fig. 1c) , and XRCC4 F111E -LIG4 did not rescue end joining in XRCC4-depleted extract (Fig. 1d ). XRCC4 K104E -LIG4 partially rescued end joining in XRCC4-depleted extract ( Fig. 1d ), in agreement with the residual low-affinity interaction between XRCC4 K104E and XLF ( Fig. 1a and Supplementary  Fig. 1e ,f). Together, these results suggest that in frog egg extract, as in mammals, the interaction between XLF and XRCC4 is required for end joining.
XLF-XRCC4 interaction is required for short-range synapsis of DNA ends. We previously described two related single-molecule fluorescence assays for monitoring synaptic-complex formation in egg extract 38 . In the 'intermolecular' assay, a surface-tethered DNA duplex labeled with Cy3 is exposed to extract containing a DNA duplex labeled with Cy5. Colocalization of Cy3 and Cy5 without FRET reports on the formation of the LR complex, whereas the appearance of FRET indicates the formation of the SR complex, in which DNA ends are closely aligned and poised for ligation. To increase the efficiency of SR-complex formation, we also used an intramolecular assay in which a 2-kb DNA substrate labeled 7 nt from one end with Cy3 and 7 nt from the other end with Cy5 is tethered to a glass coverslip via an internal biotin ( Fig. 2a ). FRET between Cy3 and Cy5, detected by TIRF microscopy, indicates assembly of the SR complex. Because the Cy3 and Cy5 labels on the intramolecular substrate always colocalize, this assay cannot detect LR-complex assembly. Given our previous demonstration that XLF and XRCC4-LIG4 are dispensable for LR-complex formation 38 , we used the intramolecular assay to address whether the XLF-XRCC4 interaction is required for SR-complex formation. For these experiments, many fields of view were imaged sequentially, and the fraction of DNA substrates with FRET efficiency > 0.25 was plotted as a function of time after extract addition ( Fig. 2b,c) . As shown previously 38 , depletion of XLF or XRCC4 abolished SR-complex formation, and these defects were rescued by purified recombinant XLF or XRCC4-LIG4, respectively (Fig. 2b,c) . In contrast, interaction-deficient XLF L68D , XLF L117D , and XRCC4 F111E -LIG4 did not support SR-complex formation ( Fig. 2b,c) , whereas XRCC4 K104E -LIG4 exhibited low activity, in agreement with its residual binding to XLF (Fig. 2c ). Thus, a physical interaction between XLF and XRCC4 is required for the close alignment of DNA ends within the SR synaptic complex.
The above results do not distinguish whether XLF-XRCC4 interaction is required for the formation or maintenance of the SR complex. To address this question, we performed long time-course imaging experiments to compare the kinetics of SR-complex formation and dissociation in the presence of WT XRCC4 and the hypomorphic K104E mutant. To prevent ligation of DNA substrates in these experiments, we supplemented extract immunodepleted of XRCC4 with XRCC4 WT or K104E in complex with catalytically inactive LIG4 K278R . The SR complex formed at a fivefold-slower rate in the presence of XRCC4 K104E compared with XRCC4 WT (2.7 × 10 −4 ± 0.5 × 10 −4 s −1 , s.e.m., compared with 1.4 × 10 −3 ± 0.3 × 10 −3 s −1 , s.e.m.), thus suggesting that the XLF-XRCC4 interaction is required for efficient establishment of the SR complex. Once formed, however, the SR complex had an equivalent lifetime in the presence of XRCC4 K104E (129 ± 27 s) and XRCC4 WT (153 ± 23 s) ( Fig. 2d,e ), thus suggesting that the stability of the assembled SR complex becomes independent of XRCC4-XLF interaction. In both cases, the lifetime distribution of the SR complex is significantly nonexponential (P < 0.001, Lilliefors test 46 ), thus indicating that SR-complex dissociation is not governed by a single rate constant.
The SR synaptic complex contains a single XLF dimer. A model in which end synapsis involves the formation of XLF-XRCC4 Table 2 ). Source data for b and c are available with the paper online. d, Sample smFRET trajectories showing SR-complex formation and dissociation in XRCC4immunodepleted extract supplemented with either XRCC4 WT -LIG4 K278R or XRCC4 K104E -LIG4 K278R . Catalytically inactive LIG4 K278R was used here and in e to prevent ligation of DNA ends. e, Cumulative distribution functions of SR-complex lifetimes. The difference between the two conditions was not statistically significant (P = 0.45, log-rank test; sample sizes in Supplementary Table 3 ). The data shown in b and c were collected with a 0.5-s exposure time, alternating between two frames of Cy3 excitation and one frame of Cy5 excitation. The data shown in d and e were collected with a 1-s exposure with a 1-s delay between exposures, alternating between four frames of Cy3 excitation and one frame of Cy5 excitation.
filaments predicts binding of numerous XLF dimers to each pair of DNA ends. To determine the stoichiometry of XLF within the synaptic complex, we used three-color imaging of Cy3/Cy5-labeled DNA ends and Alexa Fluor 488-labeled, Halo-tagged XLF (AF488-XLF). AF488-XLF rescued end joining in XLF-immunodepleted extract, thus demonstrating that XLF labeled in this manner is functional ( Supplementary Fig. 2a ). Three-color imaging allowed us to quantify binding of AF488-XLF to DNA substrates while also monitoring FRET between Cy3-and Cy5-labeled DNA ends ( Fig. 3a ). Biotinylated AF488-Halo tag deposited on the coverslip surface was used as an internal standard to determine the intensity of single AF488 fluorophores in egg extract (Methods). At any instant, most DNA substrates exhibited no AF488 signal ( Fig. 3b , black curve). Given that AF488-XLF monomer was 68% labeled, on the basis of UV-visible absorbance measurements (Methods), this result implies low average occupancy of XLF on DNA substrates, and it is inconsistent with widespread formation of XLF-XRCC4 filaments under these conditions. We next focused on substrates that undergo a transition to the SR complex, as indicated by the appearance of FRET between Cy3 and Cy5. Strikingly, SR-complex formation was typically preceded by steplike AF488-XLF binding events ( Fig. 3a and Supplementary Fig. 2f ).
The number of AF488 fluorophores present within 10 s of SR-complex formation, determined by comparison with the internal single-AF488 standard, was mostly between 0 and 2 ( Fig. 3b , red curve), in agreement with binding of a single incompletely labeled dimer of XLF. To test this interpretation, we fit the distribution of fluorophore number in the AF488 frame just before SR-complex formation to a binomial distribution with n = 2 ( Supplementary  Fig. 2e ). The fraction of labeled XLF obtained from the fit (0.60; bootstrap 95% confidence interval, 0.46-0.71) is in good agreement with the value of 0.68 estimated from absorbance measurements. An ensemble average of XLF stoichiometry, aligned at the time of SR-complex formation and corrected for the labeled fraction, showed a peak occupancy of approximately two XLF monomers (i.e., one XLF dimer) several seconds before SR-complex formation (Fig. 3c , blue curve). No such peak was observed in the absence of labeled protein ( Fig. 3c , black curve), thus ruling out a photophysical artifact. Similar results were obtained when Halo-XLF was labeled with Cy5 (Cy5-XLF; Fig. 3c , red curve, and Supplementary Fig. 3a-c) . Remarkably, despite the ability of Halo-XLF to support NHEJ with similar efficiency as untagged XLF ( Supplementary Fig. 2a ), a mixture of Halo-XLF and XRCC4 did not bridge DNA in bulk pulldown experiments ( Supplementary Fig. 1h ), thus indicating that the DNA-bridging activity detected by this pulldown assay is not essential for NHEJ. To ensure that the observed low stoichiometry of XLF in single-molecule experiments was not due to the inability of Halo-XLF to form DNA-bridging filaments with XRCC4, we labeled untagged XLF on endogenous cysteines with Cy5-maleimide. Cy5-maleimide-labeled XLF (Cy5-mal-XLF) rescued end joining in XLF-depleted extract ( Supplementary Fig. 3d ), and, unlike Halo-XLF, it assembled DNA-bridging complexes with XRCC4 in bulk pulldown experiments ( Supplementary Fig. 3e ). Nonetheless, Cy5mal-XLF still bound with an average stoichiometry consistent with one dimer per DNA substrate at the time of SR-complex formation (Fig. 3d ). These results suggest that SR-complex formation involves binding of a single XLF dimer.
End synapsis requires interaction of both XLF head domains with XRCC4.
Although our data indicate that extensive XLF-XRCC4 filaments are not required for SR-complex formation, the possibility remained that both subunits of the XLF dimer might be required to interact with XRCC4. To address this possibility, we generated an XLF tandem dimer construct (tdXLF; Fig. 4a ) in which the number of XRCC4 interaction sites could be precisely defined. tdXLF had the same molecular weight as the WT XLF dimer, as measured by size-exclusion chromatography with multiangle light scattering ( Supplementary Fig. 4a,b ). End joining in XLF-immunodepleted egg extract was rescued by tdXLF, thus demonstrating that this construct functioned in NHEJ ( Fig. 4b,c ). To test whether interaction with XRCC4 on both sides of the XLF dimer is required for end joining, we supplemented XLFdepleted extract with tdXLF WT/WT or tdXLF WT/L68D L117D , in which the second XLF sequence in the tandem dimer was mutated to prevent interaction with XRCC4 ( Fig. 4a ). Whereas tdXLF WT/L68D L117D partially rescued end joining, its activity was impaired ~8-to 16-fold relative to tdXLF WT/WT -an impairment greater than would be expected from a 50% decrease in the effective concentration of WT XLF head domains (Fig. 4b,c ). Equivalent results were obtained for the tdXLF WT/L117D single mutant (data not shown). Importantly, tdXLF WT/L68D L117D exhibited a 15-fold decrease in the SR-complex formation rate (1.9 × 10 −4 ± 1.1 × 10 −4 s −1 ) relative to tdXLF WT/WT (2.8 × 10 −3 ± 1.1 × 10 −3 s −1 ) in intramolecular smFRET circularization assays ( Fig. 4d ). However, a low level of SR-complex formation and end joining still occurred ( Fig. 4b-d ).
Given the presence of two interaction-blocking mutations, this residual activity of tdXLF WT/L68D L117D is unlikely to reflect binding of the mutant head domain to XRCC4. Thus, binding of XRCC4 to both head domains of XLF is required to form the SR complex with normal efficiency, whereas binding of a single XLF head domain to XRCC4 permits SR-complex formation at a substantially slower rate. As an independent means of examining the requirement for XRCC4-XLF interaction through both XLF head domains, we generated synthetic XLF heterodimers by coexpression of XLF monomers with different affinity tags, then performed tandem affinity purification (Methods). The exchange of monomers between purified XLF dimers was negligible ( Supplementary Fig. 4c,d) . In agreement with results for tdXLF, XLF heterodimers with one WT subunit and one L117D mutant subunit were severely deficient in end joining, as compared with WT-WT heterodimers ( Supplementary  Fig. 4e ,f). Together, these results indicate that efficient SR-complex formation and end joining require that both head domains of a single XLF monomer interact with XRCC4.
NHEJ requires XLF-XRCC4 binding but not DNA bridging by filaments. As noted above, N-terminally Halo-tagged XLF supports end joining despite being unable to bridge DNA in a pulldown assay ( Supplementary Figs. 1h and 2a ). The behavior of this fusion protein is reminiscent of that of the L115A mutant of human XLF, which cannot bridge DNA in vitro yet rescues the DNA-damage sensitivity of various XLF-deficient cell lines 17, 47 . To investigate further whether the in vitro DNA-bridging activity of XLF is separable from its function in end joining, we examined the corresponding L117A mutant in X. laevis XLF. Similarly to hXL-F L115A , XLF L117A did not bridge DNA in pulldown experiments with XRCC4 ( Fig. 5a ). However, XLF L117A supported robust end joining in XLF-immunodepleted egg extract (Fig. 5b) . Previous results from a native-PAGE binding assay suggest that hXLF L115A is deficient in interacting with XRCC4 (ref. 11 ). In contrast, our quantitative BLI measurements revealed that both hXLF L115A and Xenopus XLF L117A interact with XRCC4 with apparent K d values similar to those of WT XLF ( Fig. 5c and Supplementary Table 1 ). The finding that XLF L117A (hXLF L115A ) interacts with XRCC4 and supports NHEJ despite not bridging DNA in vitro suggests that DNA bridging by XLF-XRCC4 filaments is not essential for NHEJ.
Discussion
Despite years of study, the mechanism of DNA-end synapsis during NHEJ has remained elusive. To address this problem, we used Xenopus egg extract, which contains the entire soluble egg proteome and supports highly efficient end joining that requires all four core NHEJ factors (Ku, DNA-PKcs, XLF, and XRCC4-LIG4). Using single-molecule imaging in egg extract, we found that the XLF-XRCC4 interaction is essential for close alignment of DNA ends within the SR complex. We further demonstrated that a single XLF dimer, interacting with XRCC4 through both head domains, binds DNA ends immediately before SR-complex formation. Our results shed light on the previously obscure role of XLF in NHEJ and indicate that end joining involves the juxtaposition of DNA ends in a stoichiometrically well-defined complex.
Our results suggest that within the SR complex, a single XLF dimer bridges two XRCC4-LIG4 complexes (Fig. 5d ). Formation of an (XLF) 2 -((XRCC4) 2 -LIG4) 2 ternary complex is consistent with results from size-exclusion chromatography of XLF-XRCC4-LIG4 mixtures 48 . Such a complex has also been proposed on the basis of structural data suggesting that steric occlusion from fulllength LIG4 may permit binding of only a single XLF dimer to XRCC4-LIG4 (refs 13, 15 ). Precisely how the XLF-XRCC4-LIG4 ternary complex facilitates SR-complex formation remains unclear. Supplementary  Dataset 1 . c, BLI of XRCC4 binding by WT and L115A or L117A mutant human and Xenopus XLF. Response curves represent the average of two experimental replicates for each condition. XLF variants were tested at a concentration of 250 nM, with the exception of hXLF L115D 1-224 , which was tested at 2 µ M. Fitted K on and K off values are listed in Supplementary Table 1 . Source data for c are available online. d, Model of the role of XLF in SR-complex assembly. Binding of both head domains of XLF to XRCC4-LIG4 is required for SR-complex formation, which may involve (i) direct engagement of both DNA ends by the XLF-XRCC4-LIG4 ternary complex or (ii) a conformational change in the DNA-PK holoenzyme that is facilitated allosterically by binding of the XLF-XRCC4-LIG4 ternary complex. In the latter model, conformational flexibility in LIG4 (red double arrows) permits binding and unbinding of the LIG4 catalytic domain to DNA ends.
One possibility is that DNA-binding motifs from XLF, XRCC4, and LIG4 directly contact DNA ends and bring them together (Fig. 5d, i) . Alternatively, assembly of the XLF-XRCC4-LIG4 subcomplex within the DNA-PK holoenzyme may induce a conformational transition of DNA-PK that aligns DNA ends (Fig. 5d, ii) . In support of the latter model, the SR complex remains stable in the presence of XRCC4 K104E , which dissociates much more rapidly from XLF than does WT XRCC4, thus suggesting that XLF-XRCC4 interactions are required only for the initial formation of the SR complex but not for its maintenance (Fig. 2e) . Given that the lifetime of the SR complex is nonexponentially distributed, characterizing the multiple kinetic steps involved in SR-complex dissociation and determining which factors influence these steps should be interesting.
There are several conceptual problems associated with the XLF-XRCC4 filament model. First, end-bridging filaments of XLF-XRCC4 should block LIG4 and other end-processing enzymes from gaining access to the DNA ends 49 . Second, how the inner channel of these filaments could accommodate the large size of DNA-PKcs is unclear. Third, some mechanism would be needed to promote stable assembly of filaments near DNA ends while preventing their assembly on the much larger quantity of unbroken DNA in the cell. Fourth, phosphorylation of XLF and XRCC4 by DNA-PK inhibits filament formation, an effect that would be expected to suppress rather than promote filament assembly near DNA ends 16, 45 . In contrast, none of these difficulties apply to a model in which XLF and XRCC4 form a short oligomer within a stoichiometrically defined synaptic complex.
Our experiments cannot rule out the possibility that XLF and XRCC4 might form filaments in cells. For instance, other proteinprotein interactions might concentrate XLF and XRCC4 within chromosomal DNA-damage-response foci in a manner that is not recapitulated on the relatively short DNA substrates in our assay. However, our observation of efficient NHEJ in the absence of XLF-XRCC4 filaments shows that these structures are not required and suggests that a careful reappraisal of the filament model is needed. In vitro DNA-bridging experiments with purified XLF and XRCC4 have generally used buffers with low ionic strength (25-75 mM KCl). In contrast, we found that DNA pulldown by XLF-XRCC4 mixtures, as well as formation of large complexes measured by dynamic light scattering, was abolished at a more physiological salt concentration of 150 mM ( Supplementary Fig. 1h,i) . A more direct line of evidence supporting XLF-XRCC4 filament formation in cells has come from super-resolution imaging of fixed cells stained with antibodies against XLF and XRCC4 (ref. 27 ). XLF and XRCC4 appeared punctate in these experiments, and a subset of puncta exhibited an elongated morphology suggestive of filaments. However, further characterization of these structures is needed, because colocalization of points in super-resolution imaging does not prove the existence of physically continuous filaments. Moreover, whether XLF-XRCC4 interaction is required for focus formation remains to be tested (e.g., by analysis of mutants).
Previously, human XLF L115A was shown to rescue the DNAdamage sensitivity of most XLF-deficient mammalian cell lines despite being unable to bridge DNA in vitro, thus calling into question whether XLF-XRCC4 filaments are generally required for NHEJ 17, 47 . Likewise, we observed that X. laevis XLF L117A (corresponding to hXLF L115A ) and N-terminally Halo-tagged XLF supported NHEJ in egg extract despite exhibiting no DNA-bridging activity in a pulldown assay (Figs. 3a-c and 5a,b and Supplementary  Figs. 1h and 2a ). We found that, contrary to previous qualitative observations 11 , hXLF L115A is not deficient in hXRCC4 binding ( Fig. 5c and Supplementary Table 1 ). These results support the idea that, as in our cell-free extract, end joining in cells requires XLF-XRCC4 interaction but not DNA bridging by XLF-XRCC4 filaments.
In summary, a single XLF dimer, interacting through both head domains with XRCC4, promotes the close alignment of DNA ends. This result suggests that rather than being tethered by protein filaments, DNA ends are precisely aligned within a stoichiometrically defined protein complex. Reconstitution and structural characterization of this complex should be an important direction for future work.
online content
Any methods, additional references, Nature Research Reporting Summary, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41594-018-0120-y.
Methods
Plasmid construction. XLF and XRCC4-LIG4 expression constructs. WT X. laevis XLF, XRCC4, and LIG4 plasmids were as previously described 38 . A plasmid encoding human XRCC4 was obtained from Addgene (#13331) and was found to contain a single-nucleotide substitution resulting in the amino acid change I134T. This was restored to the reference sequence by site-directed mutagenesis, and the XRCC4 coding sequence was subcloned into a H10-SUMO expression vector. For human XLF, a bacterial codon-optimized gene block (Integrated DNA Technologies) was cloned into a H10-SUMO expression vector. Point mutants, epitope-tagged proteins, and C-terminally truncated XLF 1-226 were generated by standard round the horn site-directed mutagenesis 50 . An H10-SUMO-Halo-XLF expression plasmid was created by isothermal assembly of a Haloencoding fragment and a PCR product of the original H10-SUMO-XLF plasmid. A dual expression vector for XRCC4 and H6-SUMO-LIG4 K278R was constructed by amplifying XRCC4, H6-SUMO, and LIG4 from previously described plasmids 38 , and inserting the fragments in a pETDuet vector by isothermal assembly. All constructs were verified by Sanger sequencing.
Tandem XLF dimer. A custom Python script was used to generate a second codon-optimized XLF sequence (XLF′ ) as dissimilar as possible from our existing codon-optimized XLF sequence, to facilitate cloning and to prevent recombination between the two XLF sequences. Additional sequence encoding the linker GGGSGGGSGGGSGGG was appended at the 3′ end of the XLF′ sequence, and this combined fragment was ordered as a gBlock from Integrated DNA Technologies, inserted into a cloning vector, and sequence verified. The XLF′ + linker sequence was then inserted by isothermal assembly immediately upstream of the initial XLF methionine in H10-SUMO-XLF 38 , thus yielding the tandem dimer H10-SUMO-XLF′ -linker-XLF.
XLF heterodimers.
A plasmid for expression of H10-tagged XLF (pTG355) was created by using round-the-horn mutagenesis to delete the SUMO tag in H10-SUMO-XLF (pTG296). The alternative codon-optimized XLF sequence described above was inserted together with a T7 promoter and an N-terminal Flag-Avitag sequence into the H10-XLF plasmid, thereby generating a vector for dual expression of two versions of XLF with different affinity tags.
Protein purification. XLF. Plasmids encoding H10-SUMO-tagged WT XLF and XLF point mutants were transformed into Escherichia coli BL21(DE3)pLysS cells. Cultures were grown in LB medium at 37 °C to an OD 600 of ~0.6, IPTG was added to a final concentration of 1 mM to induce expression, and cultures were grown an additional 3 h at 25-30 °C. Cells were collected by centrifugation, and cell pellets were flash-frozen in liquid nitrogen and stored at -80 °C. H10-SUMO-tagged proteins were purified essentially as described previously 51 . Briefly, cells were lysed by sonication in His-SUMO lysis buffer (20 mM Tris-HCl, pH 8, 1 M NaCl, 30 mM imidazole, 5 mM BME, and 1 mM PMSF), and lysates were clarified by centrifugation for 1 h at 25,000 r.p.m. in an SW-41 rotor at 4 °C. Clarified lysates were incubated with Ni-NTA-agarose (Qiagen) for 1 h at 4 °C to bind histidinetagged proteins. Ni-NTA resin was washed extensively with lysis buffer followed by 'salt-reduction' buffer (20 mM Tris-HCl, pH 8, 350 mM NaCl, 30 mM imidazole, and 5 mM BME). Protein was eluted with elution buffer (20 mM Tris-HCl, pH 8, 350 mM NaCl, 300 mM imidazole, and 5 mM BME). Peak elution fractions were pooled, H6-tagged Ulp1 protease was added to cleave the H10-SUMO tag, and the protein was dialyzed overnight against His-SUMO dialysis buffer (20 mM Tris-HCl, pH 8, 350 mM NaCl, 10% glycerol, 10 mM imidazole, and 5 mM BME). The dialysate was then incubated again with Ni-NTA resin for 1.5 h at 4 °C to remove H10-SUMO, uncleaved H10-SUMO-XLF, and H6-Ulp1. The flow through (containing untagged XLF) was collected and diluted with 1.36 volumes of SP buffer A (50 mM Na-MES, pH 6.5, 10% glycerol, and 1 mM DTT) and passed over SP Sepharose Fast Flow (Amersham) equilibrated with SP buffer A + 150 mM NaCl. The resin was washed with SP buffer A + 150 mM NaCl, and protein was eluted with SP buffer A + 300 mM NaCl. Protein aliquots in this buffer were flashfrozen in liquid nitrogen and stored at -80 °C.
Halo-XLF. Halo-XLF was expressed as a H10-SUMO fusion and subjected to
Ni-NTA purification as described for H10-SUMO-XLF above. The flow through after the second Ni-NTA step was subjected to size-exclusion purification on a HiPrep Sephacryl S-200 26/60 High Resolution column equilibrated with His-SUMO dialysis buffer (20 mM Tris-HCl, pH 8, 350 mM NaCl, 10% glycerol, 10 mM imidazole, and 5 mM BME). Peak fractions were pooled and concentrated on a 15-ml 10-kDa molecular-weight cutoff (MWCO) centrifugal concentrator. XLF 1-226 truncation mutant. XLF truncation mutants were expressed as fusions to H10-SUMO in BL21(DE3)pLysS cells and subjected to the same initial His-SUMO purification protocol used for full-length XLF. Flow through from the second Ni-NTA step was diluted with approximately 2.5 volumes of 20 mM Tris-HCl, pH 8, 10% glycerol, and 5 mM BME to decrease the NaCl concentration to ~100 mM. The diluted sample was passed over a Mono Q column equilibrated with 20 mM Tris-HCl, pH 8, 100 mM NaCl, 10% glycerol, and 5 mM BME. The flow through, containing the protein of interest, was concentrated with an Amicon 10-kDa MWCO centrifugal concentrator and dialyzed overnight against 20 mM Tris-HCl, pH 8, 350 mM NaCl, 10% glycerol, and 5 mM BME. Human XLF 1-224 was purified through the same protocol. However, it bound the MonoQ column and was eluted with a NaCl gradient of 100-1,000 mM.
XLF tandem dimer. XLF tandem dimer constructs were expressed as fusions to H10-SUMO in BL21(DE3)pLysS cells and subjected to the His-SUMO purification described above for WT XLF. Flow through from the second Ni-NTA step was diluted with 1.36 volumes of buffer A (50 mM Na-MES, pH 6.5, 10% glycerol, and 5 mM BME) and bound to a HiTrap SP HP column equilibrated with the same buffer containing 150 mM NaCl. The protein was eluted with a gradient of 150 mM to 1 M NaCl over 20 column volumes (CV). Peak fractions were pooled, concentrated on a 10-kDa MWCO Amicon centrifugal concentrator, and subjected to size-exclusion purification on a Superdex 200 Increase 10/300 column equilibrated with 50 mM Na-MES, pH 6.5, 350 mM NaCl, 10% glycerol, and 5 mM BME. Peak fractions were pooled and concentrated as described above.
XLF heterodimers. BL21(DE3) cells were cotransformed with the BirA biotin ligase expression plasmid pBirAcm and a dual-expression plasmid encoding H10-XLF as well as Flag-Avitag-XLF WT (pTG448) or Flag-Avitag-XLF L117D (pTG449). After the cells had grown to an OD 600 of 0.4, expression was induced by addition of IPTG to 1 mM, and the growth medium was supplemented with biotin to a final concentration of 25 µ M. Cells were collected by centrifugation after 3 h of induction at 25-30 °C, flash-frozen, and stored at -80 °C. Frozen cell pellets were resuspended in 20 mM Tris-HCl, pH 8, 1 M NaCl, 30 mM imidazole, and 5 mM BME and lysed by three 30-s cycles of sonication (1 s on, 1 s off). Lysates were clarified by centrifugation for 1 h at 25,000 r.p.m. in an SW-41 rotor. Supernatants were incubated for 1 h at 4 °C with 250 µ l of Ni-NTA agarose (Qiagen) per liter of culture. Resin was washed with 40 CV of lysis buffer, and H10-tagged complexes were eluted with 20 CV of the same buffer containing 300 mM imidazole. Next, eluates were passed by gravity flow over SoftLink Avidin resin (Promega; 1 ml per liter of culture) to capture Avitagged H10-XLF-Flag-Avitag-XLF heterodimers. The resin was washed with 25 CV of 20 mM Tris-HCl, pH 8, 1 M NaCl, and 5 mM BME, followed by 5 CV of 20 mM Tris-HCl, pH 8, 350 mM NaCl, and 5 mM BME. We suspect that the use of high-salt buffers at this stage is important to remove nonspecifically bound H10-XLF WT -H10-XLF WT homodimer, because early WTmutant heterodimer preparations purified under less stringent conditions exhibited variable and elevated activity (data not shown). Bound protein was eluted in 1-CV increments with 20 mM Tris-HCl, pH 8, 350 mM NaCl, 5 mM BME, and 5 mM biotin, with a pause of at least 5 min between elution steps to facilitate dissociation of bound protein. Protein was flash-frozen and stored at -80 °C in elution buffer.
XRCC4. N-terminal H10-SUMO fusion constructs of X. laevis XRCC4 were transformed into BL21(DE3)pLysS E. coli cells. The cells were grown at 37 °C to an OD 600 of 0.6 and then induced with 1 mM IPTG for 3 h at ~25-30 °C. Cells were pelleted by centrifugation, flash frozen, and stored at -80 °C. Cell pellets were then thawed and subjected to the His-SUMO purification used previously 38 .
Biotinylated XRCC4-Avitag. X. laevis XRCC4 with an N-terminal H10-SUMO tag and a C-terminal Avitag was expressed in BL21(DE3) E. coli cells cotransformed with the BirA biotin ligase-expressing plasmid pBirAcm. Cells were grown in LB medium supplemented with 100 µ M biotin, and protein expression was induced with 1 mM IPTG for 3 h at ~25-30 °C. Protein was subjected to the same initial H10-SUMO purification steps used for XLF (described above). Biotinylated protein was then bound to SoftLink Avidin resin equilibrated with 20 mM Tris-HCl, pH 8, 150 mM NaCl, 10% glycerol, and 1 mM DTT. The resin was washed with 20 CV of the same buffer, and protein was eluted with elution buffer (20 mM Tris-HCl, pH 8, 150 mM NaCl, 10% glycerol, 1 mM DTT, and 5 mM biotin). Elution was performed in increments of 2 CV, with a pause of 5 min between elutions. Peak fractions were pooled and dialyzed overnight against 20 mM Tris-HCl, pH 8, 350 mM NaCl, 10% glycerol, and 1 mM DTT. Human XRCC4-Avitag was purified with the same protocol.
XRCC4-LIG4 complex. WT and mutant XRCC4-LIG4 complexes were expressed in Sf9 cells and purified as described previously 38 . Catalytically inactive XRCC4-LIG4 K278R complexes (for the experiments in Fig. 2d,e ) were expressed from a pETDuet vector in Rosetta 2 (DE3) E. coli cells. Cultures were grown at 37 °C to an OD 600 of 0.6 and then placed on ice for 20 min. IPTG was added to a final concentration of 1 mM, and cultures were incubated with shaking for 16 h at 17 °C. Cells were pelleted by centrifugation, flash frozen, and stored at -80 °C. Cell pellets were thawed and resuspended in 20 ml of lysis buffer (20 mM HEPES, pH 7.5, 400 mM NaCl, 20 mM imidazole, 10% glycerol, 1 mM DTT, and one cOmplete, EDTA-free Protease Inhibitor tablet (Sigma Aldrich)) per liter of culture. The resuspension was sonicated for 2 min (5 s on, 10 s off). Lysates were clarified by 1 h of centrifugation at 38,724 r.c.f. at 4 °C. The lysates were then incubated at 4 °C for 1 h with 250 µ l of Ni-NTA agarose (Qiagen) per liter of culture. The samples were centrifuged at 500 r.c.f., the supernatant was discarded, and the Ni-NTA resin was resuspended in 10 ml of lysis buffer and poured into a gravity-flow column. The resin was then washed with 20 ml of lysis buffer, and protein was eluted in 250-µ l fractions with lysis buffer containing 250 mM imidazole. Fractions containing the protein of interest were pooled, supplemented with Ulp1 protease, and dialyzed into cleavage buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM DTT, and 10% glycerol). The dialyzed sample was then incubated with 250 µ l of Ni-NTA resin per liter of culture for 1.5 h at 4 °C. The flow through was collected, passed through a 0.22 μ m filter, and diluted in cleavage buffer without NaCl to bring the final NaCl concentration to 50 mM. Protein was bound to a MonoQ 5/50-GL column (GE Healthcare Life Sciences) equilibrated in buffer A (cleavage buffer with 50 mM NaCl) and eluted with a 20-ml gradient of 0-60% buffer B (cleavage buffer with 1 M NaCl). Peak fractions were pooled and further separated on a S200 16/600 200-pg sizing column (GE Healthcare Life Sciences) equilibrated with cleavage buffer. Protein-containing fractions were pooled and concentrated with an Amicon 10-kDa MWCO centrifugal concentrator.
Biotin-Avitag-Halo. N-terminally SUMO-tagged Avitag-Halo protein was expressed in BL21(DE3) cells containing the pBirAcm plasmid, which encodes the BirA biotin ligase. It was subjected to the same His-SUMO purification procedure used for XLF, without the final ion-exchange step.
Flag-XLF and H10-XLF (for monomer-exchange experiments).
A Flag-XLF expression plasmid was transformed into BL21(DE3) pLysS cells, which were grown in 100 ml of LB to an OD 600 of 0.4, induced with 1 mM IPTG for 3 h at 25-30 °C, and collected by centrifugation. Cells were lysed in 20 mM Tris-HCl, pH 7.5, and 150 mM NaCl, without reducing agent. The lysate was clarified by centrifugation at 16,000 r.c.f. in a 4 °C microcentrifuge and incubated with 50 μ l of anti-Flag M2 affinity gel (Sigma-Aldrich) for 1 h at 4 °C. The gel was washed three times with 1.4 ml of lysis buffer, and protein was eluted by overnight incubation at 4 °C with 100 μ g/μ l of 3× Flag peptide (Sigma-Aldrich). Protein was dialyzed against storage buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10% glycerol, and 5 mM BME) with a 7-kDa MWCO dialysis cassette, divided into aliquots, flashfrozen, and stored at -80 °C. H10-XLF was expressed in BL21(DE3) pLysS cells under the same growth and induction conditions used for H10-SUMO-XLF. Initial Ni-NTA purification followed the same steps as for H10-SUMO-XLF. The protein was dialyzed overnight against 20 mM Na-MES, pH 6.5, 150 mM NaCl, 10% glycerol, and 5 mM BME; bound to a Mono S column; and eluted with a gradient of the same buffer with 150 mM to 1 M NaCl. Peak fractions were pooled and dialyzed overnight against 20 mM Tris-HCl, pH 7.5, 350 mM NaCl, 10% glycerol, and 1 mM DTT. Protein was concentrated with a centrifugal concentrator, divided into aliquots, flash-frozen, and stored at -80 °C.
Test of monomer exchange between XLF dimers. To assess whether monomers are exchanged between XLF dimers in solution ( Supplementary Fig. 4d) , we mixed N-terminally Flag-and H10-tagged XLF proteins at final concentrations of 8 μ M and 20 μ M, respectively, in a 5-μ l volume of 20 mM Tris-HCl, pH 7.5, 250 mM NaCl, 10% glycerol, 2.5 mM BME, and 0.5 mM DTT. Control reactions contained only one protein or the other. Reactions were incubated for 3 h at room temperature in a humidified chamber. 100 μ l of His-SUMO lysis buffer was added (20 mM Tris-HCl, pH 8, 1 M NaCl, 30 mM imidazole, and 5 mM BME), and tubes were centrifuged for 10 min at 16,000 r.c.f. in a 4 °C microcentrifuge. No pellet was visible. After 15 μ l of supernatant was withdrawn for analysis, 80 μ l of supernatant was incubated for 1 h at 4 °C with 10 μ l of Ni-NTA-agarose resin prewashed with His-SUMO lysis buffer. Supernatant was collected, and the resin was washed twice with 500 μ l of His-SUMO lysis buffer, with thorough aspiration after each wash. 80 μ l of His-SUMO elution buffer was added (20 mM Tris-HCl, pH 8, 350 mM NaCl, 300 mM imidazole, and 5 mM BME), and protein was eluted for 30 min at 4 °C. Input, supernatant, and eluate samples were separated on a 4-15% precast SDS-PAGE gel (Bio-Rad), transferred to polyvinylidine fluoride membranes for 1 h at 100 V at 4 °C, and blocked with 5% powdered nonfat milk in PBST (1× phosphate-buffered saline with 0.05% Tween 20). Membranes were probed overnight with 1:5,000 anti-H6 (Sigma-Aldrich) or 1:5,000 anti-FLAG M2 (Sigma-Aldrich), washed three times with PBST, and probed for 1 h with 1:20,000 horseradish peroxidase-conjugated rabbit anti-mouse IgG (H + L) secondary antibody (Jackson ImmunoResearch 315-035-003). After being washed again three times with PBST, the anti-H6 blot was incubated with chemiluminescent horseradish peroxidase substrate (HyGLO Quick Spray, Denville Scientific), and the anti-Flag blot was incubated with enhanced chemiluminescent substrate (Pierce). Both blots were imaged on an Amersham Imager 600 (GE Healthcare Life Sciences).
Preparation of sulfo-Cy5-Halo substrate. 8 µ l of 100 mM Cy5-NHS ester in DMSO was combined with 3.2 μ l of 250 mM HaloTag amine (O2) ligand (Promega) and 38.8 μ l of 100 mM sodium bicarbonate and allowed to react overnight. The products were separated by reversed-phase HPLC on a semipreparative C18 column with a gradient of 20-100% acetonitrile in water. Product identity was verified by mass spectrometry. Peaks corresponding to the correct product were pooled, and solvent was evaporated overnight with a SpeedVac concentrator. The compound was redissolved in DMSO, and the concentration was determined according to the absorbance at 650 nm of a 1:100 dilution in water, assuming an extinction coefficient of 250,000 M −1 cm −1 for Cy5.
Fluorescence labeling of Halo-XLF. A twofold molar excess of Cy5-or Alexa Fluor 488-Halo ligand in DMSO was added to Halo-XLF protein in its storage buffer. The mixture was allowed to react for 10 min while being centrifuged at 16,000 r.c.f. at room temperature. Labeled protein was separated from free dye on a Superdex 200 Increase 10/300 column equilibrated with 20 mM Tris-HCl, pH 8, 350 mM NaCl, 10% glycerol, and 5% β -mercaptoethanol. Peak fractions were pooled and concentrated with an Amicon 10-kDa MWCO centrifugal concentrator. Protein concentrations were measured on the basis of absorbance at 280 nm, assuming an extinction coefficient of 82,390 M −1 cm −1 . Dye concentrations were measured according to absorbance at 650 nm for Cy5 (assuming an extinction coefficient of 250,000 M −1 cm −1 ) or 495 nm for AF488 (assuming an extinction coefficient of 73,000 M −1 cm −1 ). For AF488-labeled protein, the absorbance at 280 nm due to protein was determined by subtraction of the AF488 absorbance at 280 nm from the total absorbance, with the correction factor (AF488 absorbance at 280 nm) = 0.11 × (AF488 absorbance at 495 nm). The labeled fraction of monomer was obtained by division of the molar concentration of dye by the molar concentration of protein. Measurements of the labeled fraction obtained with a NanoDrop spectrophotometer agreed with those calculated from dual-wavelength absorbance measurements of labeled protein peaks during size-exclusion chromatography.
Fluorescence labeling of XLF with Cy5-maleimide. 130 μ l of 53 μ M WT X. laevis XLF was incubated for 1 h at room temperature with 50 μ M sulfo-Cy5 maleimide (Lumiprobe) in 20 mM Tris-HCl, pH 7.5, 350 mM NaCl, and 10% glycerol. The labeling reaction was quenched by the addition of DTT at a final concentration of 5 mM. Labeled protein was separated from free dye on an S200 Increase 10/300 GL sizing column (GE Healthcare Life Sciences). Protein-containing fractions were collected, and the Cy5:XLF ratio was determined according to the absorbance of each, measured with a NanoDrop spectrophotometer. With an extinction coefficient of 250,000 M −1 cm −1 for Cy5 and an extinction coefficient of 24,450 M −1 cm −1 for XLF, the dye-to-protein ratio was measured to be 0.77. This same procedure was performed in parallel for an AF488-labeled XLF sample and a mock-labeled XLF sample.
Preparation of Xenopus egg extracts.
Xenopus egg extract was prepared as previously described 52 . The female frogs used to produce oocytes were cared for by the Center for Animal Resources and Comparative Medicine at Harvard Medical School (AAALAC accredited). Work performed for this study was in accordance with the rules and regulations set by AAALAC. The Institutional Animal Care and Use Committee (IACUC) of Harvard Medical School approved the work.
Antibodies and immunodepletion. XLF and XRCC4 antibodies were the same as described previously 38 . Immunodepletion experiments were performed as described previously 37, 38 . For rescue experiments in Figs. 1c,d and 5b, immunodepleted extract was supplemented with 500 nM XLF or 50 nM XRCC4-LIG4 complex.
Bulk end-joining assays. Bulk end-joining assays were performed as described previously 38 . The final concentration of radiolabeled linear substrate DNA in bulk end joining assays was approximately 1 ng/µ l (~0.5 nM). The integrated intensity of gel bands ( Fig. 4c and Supplementary Fig. 4f ) was quantified in Fiji.
tdXLF and XLF heterodimer titration experiments.
To test the dependence of the end-joining rate on the protein concentration of XLF tandem dimer (tdXLF; Fig. 4b-d ) and heterodimer ( Supplementary Fig. 4e ,f) constructs, we depleted extract of endogenous XLF, then supplemented the depleted extract with an ATPregeneration system and closed-circular carrier DNA, as described previously 37 . Radiolabeled linear substrate DNA was added to extract on ice to a final concentration of ~1 ng/µ l, and a portion of this extract mixture was supplemented with XLF at the indicated maximum concentration. The same fractional volume of XLF storage buffer was added to the remaining extract mixture. Extract supplemented with XLF was then serially diluted with extract mixture, while tubes were kept in a PCR block at 0 °C. After serial dilutions, the temperature of the block was raised to 22 °C for 5 min, then lowered to 0 °C to stop the reactions. One volume of reaction stop solution/loading dye with proteinase K 37 was immediately added to all tubes. Products were analyzed by gel electrophoresis as described previously 37 .
Microscope and flow-cell construction. Samples were imaged with a throughobjective TIRF microscope built around an Olympus IX-71 inverted microscope body. 488-nm, 532-nm, and 641-nm laser beams (Coherent Sapphire 488, Coherent Sapphire 532, and Cube 641, respectively) were expanded, combined with dichroic mirrors, expanded again, and focused on the rear focal plane of an oil-immersion objective (Olympus UPlanSApo, 100× ; NA, 1.40). The focusing lens was placed on a vertical translation stage to permit manual adjustment of the TIRF angle. Emission light was separated from excitation light with a multipass dichroic mirror, and laser lines were further attenuated with a StopLine 488/532/635 notch filter (Semrock). A home-built beamsplitter (ref. 37 ) was used to separate Alexa Fluor 488 and Cy3 emission from Cy5 emission; these two channels were imaged on separate halves of an electron-multiplying charge-coupled device camera (Hamamatsu, ImageEM 9100-13), which was operated at maximum EM gain. An automated microstage (Mad City Labs) was used to position the sample and move between fields of view.
Coverslips were functionalized with a mixture of methoxypolyethylene glycol (mPEG) and biotin-mPEG, and flow cells were constructed according to a previously described protocol 38, 53 .
Single-molecule imaging and analysis. Single-molecule imaging and analysis is described in the Supplementary Note.
Biolayer interferometry binding assays. BLI experiments were performed on an Octet RED384 (ForteBio) with streptavidin-coated Dip and Read Biosensors (ForteBio) and 384-well plates. 100 nM of biotinylated C-terminally Avi-tagged XRCC4 was bound for 5 min in a binding buffer consisting of 20 mM Tris-HCl, pH 7.5, 125 mM KCl, 10 mg/mL bovine serum albumin (Calbiochem), and 5 mM BME. To test for nonspecific binding of XLF , reference tips were incubated in buffer alone. The tips were washed with buffer for 60 s to obtain a baseline reading and then transferred to wells containing XLF or point mutants thereof (2 µ M of each protein unless otherwise noted) for 120 s. After measurement of association, the tips were moved to wells containing buffer, and XLF dissociation was measured for 180 s. The response for each experimental condition shown in Fig. 1a is the average of three replicates, and each replicate is the average of three sequential rounds of association and dissociation. The s.d. is represented as shading around each trace. The data shown in Supplementary Fig. 1a are representative results from a single experiment. For the titration experiments shown in Supplementary  Fig. 1b ,e,f, the background subtracted association-dissociation curve for each concentration was fit to a 1:1 model with GraphPad Prism software and the builtin fitting tools. Data generated from fits for which R 2 < 0.98 were not included in subsequent analysis. The resulting k on , k off , and apparent K d values were averaged. This procedure was performed for two replicates for each condition. The reported values are averages from the two replicates, and the reported error represents the minimum and maximum values. The same fitting and analysis procedure was used to generate the curves shown in Fig. 5c and the values in Supplementary Table 1 . Those data represent two experimental replicates, with the error representing the minimum and maximum values. Supplementary Fig.  1c ,i were collected at 20 °C with an acquisition time of 10 s and a read interval of 1 s. Sample measurement began ~1 min after assembly and mixing of the specified proteins in a filtered buffer containing 20 mM HEPES, pH 8, 75 mM KCl, 0.5 mM EDTA, 1 mM DTT, and 5% glycerol. Dynamics V6 software (Wyatt/Protein Solutions) was used to calculate hydrodynamic radii with the built-in parameters for a 5% glycerol solution. For each condition, three replicates were averaged to generate the data shown in Supplementary Fig. 1c ,i. The shaded region around each trace represents the s.e.m.
Bulk protein-DNA pulldown assays. DNA pulldown assays ( Supplementary  Figs. 1d,h and 3e ) were performed as previously described 25 . A biotinylated 1,000-bp DNA fragment was generated by PCR (template pTG064; primers oTG414 and oTG042F) with Pfu polymerase. The 500-bp DNA was generated by PvuII digestion of pTG024. These DNA substrates were then gel-purified by electroelution, as described previously 37 . M-280 streptavidin-coated magnetic Dynabeads (Thermo Fisher Scientific) were washed three times with one volume of binding buffer (20 mM HEPES, pH 8, 75 mM KCl, 0.5 mM EDTA, 1 mM DTT, 5% glycerol, and 400 μ g/ml BSA (New England Biolabs)), with a magnet to retain beads, then resuspended in one volume of the same buffer. Beads were incubated with 1,000-bp DNA at a final concentration of 20 ng/μ l for 5 min at 20-25 °C. One volume of high-salt buffer (binding buffer with 850 mM KCl) was used to wash the beads twice before resuspension in wash buffer. The 500-bp DNA was then added at a final concentration of 20 ng/μ l. 10 μ l of the bead-DNA suspension was added to each 40-μ l reaction assembled in binding buffer. The indicated proteins were added at a final concentration of 2 μ M, and the reactions were incubated at room temperature for 30 min. After a magnet was used to capture the beads, the supernatant was collected, and the beads were then washed twice in binding buffer and resuspended in the same buffer without BSA. 10 μ l of each sample was set aside and separated on a 4-15% SDS-PAGE gel (Bio-Rad). An Amersham Imager 600 was used to visualize Cy5-labeled XLF. The samples were then treated with 40 ng proteinase K for 1 h at 50 °C, and DNA was separated on a 1.5% agarose gel. Differential scanning fluorimetry. Differential scanning fluorimetry protein thermal-shift assays were performed with a QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems). 20-μ l reactions containing 10 μ g of the specified protein were assembled in MicroAmp FAST optical 96-well reaction plates (Life Technologies) and covered with MicroAmp Optical Adhesive Film (Life Technologies). SYPRO Orange dye was included in the reactions with a Protein Thermal Shift Dye Kit (Applied Biosystems), according to the manufacturer's instructions. Protein samples were diluted in storage buffer (20 mM Tris-HCl, pH 8, 10 mM imidazole, 350 mM NaCl, and 10% glycerol). The temperature was raised from 25 to 99 °C at 3 °C per minute, and the fluorescent dye was excited and measured at 470 nm and 587 nm, respectively. To determine the melting temperatures, we plotted emission signals as a function of temperature, and these thermal denaturation curves were fit with the Boltzmann equation in Protein Thermal Shift software (Life Technologies). The average of three experimental replicates is shown for each condition. The error bars represent the s.e.m. A twotailed, unpaired t test with unequal variance was performed to determine whether the melting temperatures of the mutants were significantly different from those of the WT proteins.
Size-exclusion chromatography with multiangle light scattering. SEC-MALS was performed on an Agilent 1260 Infinity Isocratic Liquid Chromatography System equipped with a Wyatt Dawn Heleos II Multi-Angle Light Scattering detector and a Wyatt Optilab T-rex Refractive Index Detector. An Agilent AdvanceBio 300 column was preequilibrated overnight with running buffer (50 mM Na-MES, pH 6.5, 350 mM NaCl, 10% glycerol, and 5 mM BME) at a 0.2 ml/min flow rate and then allowed to equilibrate to a flow rate of 0.4 ml/min for 1 h. 30 μ l of a 50 μ M solution of tdXLF WT/WT was separated on the column. As a control, 100 μ l of 2 mg/ml BSA fraction V (OmniPur) in the same buffer without BME was separated on the column, thus yielding monomer, dimer, and trimer peaks of the expected sizes.
Statistics and reproducibility.
A two-tailed unpaired t test with unequal variances was used to determine significance (P < 0.05) in Supplementary Fig. 1e -g. Bonferroni correction was applied in the case of Supplementary Fig. 1g . A log-rank test was used to determine significance (P < 0.05) in Fig. 2e . The Lilliefors test for exponential distribution (MATLAB function 'lillietest') was applied to the data shown in Fig. 2e . For figures that include representative images, the number of experimental replicates of the corresponding experiments are: two for Fig. 1c,d , three for Fig. 3b ,c, three for Fig. 5a , two for Fig. 5b , two for Supplementary Fig. 1a , two for Supplementary  Fig. 2b , three for Supplementary Fig. 1d , two for Supplementary Fig. 1h , five for Supplementary Fig. 2a , two for Supplementary Fig. 3d , two for Supplementary  Fig. 3e , two for Supplementary Fig. 4d , and six for Supplementary Fig. 4e ,f. The exact experimental conditions were varied slightly between replicates of some experiments, and appropriate internal controls were used in all cases. Similar results were obtained among replicates for all experiments listed above. 
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Data collection
The collection of all single-molecule data is described in the Methods section under 'Single-molecule imaging and analysis'. ForteBio Octet 384 Data Acquisition 9.0 software was used collect all bio-layer interferometry data. Wyatt/Protein Solutions Dynamics V6 software was used to collect dynamic light scattering data. Life Technologies Protein Thermal Shift software was used to collect differential scanning fluorimetry data.
Data analysis
The software used and analysis of all single-molecule data is described in the Methods section under 'Single-molecule imaging and analysis'. ForteBio Octet 384 Data Analysis 8.0 software and GraphPad Prism software were used analyze all bio-layer interferometry data as described in the Methods section under 'Bio-layer interferometry (BLI) binding assays'. Wyatt/Protein Solutions Dynamics V6 software was used to analyze dynamic light scattering data as described in the Methods section under 'Dynamic light scattering'. Life Technologies Protein Thermal Shift software was used to analyze differential scanning fluorimetry data as described in the Methods section under 'Differential scanning fluorimetry'. Results from gel-based assays were quantified using Fiji.
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Data exclusions BLI response curves for which fitting to a 1:1 model as described in the Methods section, 'Bio-layer interferometry (BLI) binding assays' generated R-square values less than 0.98 were not included in subsequent analysis. Poor fitting to this model only occurred at very low concentrations of the protein being titrated where the measurable response was minimal. For single-molecule data analysis, spots were excluded if they showed evidence of containing more than one DNA substrate. Details are provided in the Methods. Randomization Randomization was not relevant to this study.
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